Latest News and Press Releases
Want to stay updated on the latest news?
-
Junshi Biosciences and Fosun Wanbang will cooperate on the development and commercialization of roconkibart in the Greater China Region.
-
BLA of Roconkibart (IL-17A) for the treatment of moderate to severe plaque psoriasis has been accepted by the NMPA